{
  "trial_id": "NCT01428089",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Inpatient Admission",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hemoglobin \u2265 11.0 g/dL for African American subjects or \u2265 11.5 g/dL for non-African American subjects",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnancy",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Hemoglobin less than 12 g/dl and hematocrit less than 36%",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has myasthenia gravis, class IIa. She takes pyridostigmine 60 mg three times a day.",
  "_meta": {
    "topic_id": "38",
    "trial_id": "NCT01428089",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}